After two years, COTA was back together in NYC for an in-person all-hands meeting. As much as we have learned to adapt to the world of remote work, there is no substitute for the connection, collaboration, and energy that comes from physically being in the same space.
Working with the FDA and now COTA Laura describes why real-world data is an integral part of today’s patient care.
COTA Promotes Paige Whitney to Senior Vice President to Expand the Use of Real-World Data in Life Sciences
Paige Whitney will join the executive leadership team as Senior Vice President of Life Sciences. Paige is responsible for growing the company’s industry partnerships and strengthening COTA’s position as a leading provider of oncology RWD.
Diversity in clinical trials is a change that needs to be made in order to make all efforts more efficient and develop a better ending result for patients. Karla Feghali and Laura Fernandes detail why this is so necessary moving forwards.
COTA Collaborates with University of Chicago Medicine and UT Southwestern on Research To Be Presented at the American Society for Hematology’s Annual Meeting & Exposition
Four abstracts will be showcased at the American Society for Hematology’s (ASH) Annual Meeting & Exposition from December 11–14, 2021, in Atlanta, Georgia. COTA has the most comprehensive hematology oncology real-world data that is curated under the close guidance of leading oncologists and hematology specialists.
Life science stakeholders are committed to making the path to positive outcomes less frightening and convoluted for patients. With breakthrough treatments and innovative therapies targeted to the toughest of cancers, the industry has made significant progress with guiding patients toward longer, healthier lives.
In September 2021, the FDA published new draft guidance as part of its ongoing efforts to explore the use of real-world data (RWD) and real-world evidence (RWE) within its regulatory decision-making process.
As CFO, Ritu will oversee all aspects of COTA’s financial strategy as it enters the next phase of growth. She will support COTA’s overall mission of bringing clarity to cancer care by devising and implementing sound financial strategies to maximize revenue growth and operational efficiencies, increasing financial transparency and engaging with investors.
Thanks to the pandemic, remote work is more collaborative, but hiring and onboarding new employees has its share of challenges. Thankfully we were able to pivot and COTA is proud of the process we’re using to recruit new employees.
With more than 25 years of healthcare experience, Christine Kawiecki joins the COTA, Inc. team to support business growth as life sciences companies are increasingly turning to real-world data to accelerate drug development in a post-pandemic world.